Cargando…

Induction of Broadly Cross-Reactive Antibodies by Displaying Receptor Binding Domains of SARS-CoV-2 on Virus-like Particles

The impact of the COVID-19 pandemic has been reduced since the application of vaccination programs, mostly shown in the reduction of hospitalized patients. However, the emerging variants, in particular Omicron, have caused a steep increase in the number of infections; this increase is, nevertheless,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Xinyue, Liu, Xuelan, Mohsen, Mona O., Zeltins, Andris, Martina, Byron, Vogel, Monique, Bachmann, Martin F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876827/ https://www.ncbi.nlm.nih.gov/pubmed/35214764 http://dx.doi.org/10.3390/vaccines10020307

Ejemplares similares

Vaccination using mutated receptor binding domains of SARS-CoV-2: Evidence for partial immune escape but not serotype formation
por: Chang, Xinyue, et al.
Publicado: (2023)

A Novel Double Mosaic Virus-like Particle-Based Vaccine against SARS-CoV-2 Incorporates Both Receptor Binding Motif (RBM) and Fusion Domain
por: Chang, Xinyue, et al.
Publicado: (2021)

Development of a Vaccine against SARS-CoV-2 Based on the Receptor-Binding Domain Displayed on Virus-Like Particles
por: Zha, Lisha, et al.
Publicado: (2021)

Virus-Like Particles Are Efficient Tools for Boosting mRNA-Induced Antibodies
por: Vogt, Anne-Cathrine S., et al.
Publicado: (2022)

Molecular definition of severe acute respiratory syndrome coronavirus 2 receptor‐binding domain mutations: Receptor affinity versus neutralization of receptor interaction
por: Vogel, Monique, et al.
Publicado: (2021)

Low‐affinity but high‐avidity interactions may offer an explanation for IgE‐mediated allergen cross‐reactivity
por: Chang, Xinyue, et al.
Publicado: (2021)

BNT162b2 mRNA COVID‐19 vaccine induces antibodies of broader cross‐reactivity than natural infection, but recognition of mutant viruses is up to 10‐fold reduced
por: Chang, Xinyue, et al.
Publicado: (2021)

Neutralization of MERS coronavirus through a scalable nanoparticle vaccine
por: Mohsen, Mona O., et al.
Publicado: (2021)

Construction and Characterization of Virus-Like Particles: A Review
por: Zeltins, Andris
Publicado: (2012)

AP205 VLPs Based on Dimerized Capsid Proteins Accommodate RBM Domain of SARS-CoV-2 and Serve as an Attractive Vaccine Candidate
por: Liu, Xuelan, et al.
Publicado: (2021)

A scalable and highly immunogenic virus‐like particle‐based vaccine against SARS‐CoV‐2
por: Mohsen, Mona O., et al.
Publicado: (2021)

Recent Advances in the Use of Plant Virus-Like Particles as Vaccines
por: Balke, Ina, et al.
Publicado: (2020)

In vitro data suggest that Indian delta variant B.1.617 of SARS‐CoV‐2 escapes neutralization by both receptor affinity and immune evasion
por: Augusto, Gilles, et al.
Publicado: (2021)

Bacterial expression systems based on Tymovirus-like particles for the presentation of vaccine antigens
por: Ogrina, Anete, et al.
Publicado: (2023)

Intranasal administration of a VLP‐based vaccine induces neutralizing antibodies against SARS‐CoV‐2 and variants of concern
por: Rothen, Dominik A., et al.
Publicado: (2022)

Comparison of Bacterial Expression Systems Based on Potato Virus Y-like Particles for Vaccine Generation
por: Ogrina, Anete, et al.
Publicado: (2022)

Interaction of Viral Capsid-Derived Virus-Like Particles (VLPs) with the Innate Immune System
por: Mohsen, Mona O., et al.
Publicado: (2018)

Increased Receptor Affinity and Reduced Recognition by Specific Antibodies Contribute to Immune Escape of SARS-CoV-2 Variant Omicron
por: Vogt, Anne-Cathrine S., et al.
Publicado: (2022)

TLR7 Signaling Shapes and Maintains Antibody Diversity Upon Virus-Like Particle Immunization
por: Chang, Xinyue, et al.
Publicado: (2022)

Strategies for induction of HIV‐1 envelope‐reactive broadly neutralizing antibodies
por: Williams, Wilton B., et al.
Publicado: (2021)

Special Issue “Virus-Like Particle Vaccines”
por: Vogel, Monique, et al.
Publicado: (2020)

Abundant human anti-Galα3Gal antibodies display broad pathogen reactivity
por: Bernth Jensen, Jens Magnus, et al.
Publicado: (2020)

Synthesis and Immunological Evaluation of Virus-Like Particle-Milbemycin A(3)/A(4) Conjugates
por: Zeltins, Andris, et al.
Publicado: (2017)

Virus-like particle vaccinology, from bench to bedside
por: Mohsen, Mona O., et al.
Publicado: (2022)

A novel platform for virus-like particle-display of flaviviral envelope domain III: induction of Dengue and West Nile virus neutralizing antibodies
por: Chua, Anthony JS, et al.
Publicado: (2013)

Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Dengue Virus Infection
por: Cabral-Miranda, Gustavo, et al.
Publicado: (2019)

Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
por: Walls, Alexandra C., et al.
Publicado: (2021)

Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
por: Walls, Alexandra C., et al.
Publicado: (2021)

SARS-CoV-2 receptor binding domain displayed on HBsAg virus–like particles elicits protective immunity in macaques
por: Dalvie, Neil C., et al.
Publicado: (2022)

On the complexity of IgE: The role of structural flexibility and glycosylation for binding its receptors
por: Plattner, Kevin, et al.
Publicado: (2023)

SARS-CoV-2 structural features may explain limited neutralizing-antibody responses
por: Bachmann, Martin F., et al.
Publicado: (2021)

Alzheimer’s Disease: A Brief History of Immunotherapies Targeting Amyloid β
por: Vogt, Anne-Cathrine S., et al.
Publicado: (2023)

Incorporation of tetanus-epitope into virus-like particles achieves vaccine responses even in older recipients in models of psoriasis, Alzheimer’s and cat allergy
por: Zeltins, Andris, et al.
Publicado: (2017)

Characterization of a broadly cross reactive tetravalent human monoclonal antibody, recognizing conformational epitopes in receptor binding domain of SARS-CoV-2
por: Garg, Sonal, et al.
Publicado: (2022)

The 3Ds in virus‐like particle based‐vaccines: “Design, Delivery and Dynamics”
por: Mohsen, Mona O., et al.
Publicado: (2020)

An engineered vaccine of the Plasmodium vivax Duffy binding protein enhances induction of broadly neutralizing antibodies
por: Ntumngia, Francis B., et al.
Publicado: (2017)

Diphenyleneiodonium chloride (DPIC) displays broad-spectrum bactericidal activity
por: Pandey, Manitosh, et al.
Publicado: (2017)

Correction: Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Dengue Virus Infection. Vaccines 2019, 7, 72
por: Cabral-Miranda, Gustavo, et al.
Publicado: (2020)

BioWF: A Naturally‐Fused, Di‐Domain Biocatalyst from Biotin Biosynthesis Displays an Unexpectedly Broad Substrate Scope
por: Richardson, Shona M., et al.
Publicado: (2022)

Induction of Broadly Neutralising HCV Antibodies in Mice by Integration-Deficient Lentiviral Vector-Based Pseudotyped Particles
por: Deng, Yao, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_40mlct7k8n2df07i3v84c9m2a2